Synlait Sells Assets to Abbott for $307 Million to Reduce Debt

Sourse: en.edairynews.com
1376 EN 中文 DE FR عربى
Synlait Milk, a significant player in the nutrition and infant formula industry, has finalized the sale of its North Island assets, including the Pōkeno manufacturing facility, to Abbott Laboratories for about NZ$307 million (US$178 million).
Synlait Sells Assets to Abbott for $307 Million to Reduce Debt

This transaction is supported by Bright Dairy Holding, which holds a 65.25% stake in Synlait, ensuring shareholder approval.

The asset sale is primarily aimed at reducing Synlait's debt, which stood at around NZ$250.7 million. The proceeds are expected to eliminate the company's term debt by the targeted completion date of April 1, 2026. Despite reporting a full-year loss of $39.8 million due to past manufacturing issues, this move strategically positions Synlait for future growth.

Beyond financial stabilization, Synlait is shifting its focus to its South Island facilities, emphasizing high-value nutritional products over large-scale commodity processing. This strategic pivot is part of an 'orderly transition' as Synlait's key customer, The a2 Milk Company, diversifies its supply chain.


April 2026
  • Mo
  • Tu
  • We
  • Th
  • Fr
  • Sa
  • Su
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
Calendar